Abiomed (NASDAQ: ABMD)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Abiomed (NASDAQ: ABMD) through any online brokerage.
The latest price target for Abiomed (NASDAQ: ABMD) was reported by Wolfe Research on Wednesday, April 6, 2022. The analyst firm set a price target for 330.00 expecting ABMD to rise to within 12 months (a possible 38.28% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Abiomed (NASDAQ: ABMD) is $238.65 last updated May 19, 2022, 8:00 PM UTC.
There are no upcoming dividends for Abiomed.
Abiomed’s Q1 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Abiomed.
Abiomed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.